Aclaris Therapeutics, Inc. (ACRS) Operating margin 2017–2025
Aclaris Therapeutics, Inc. (ACRS) operating margin by fiscal year — reported operating income divided by reported revenue.
-975.9%FY2025 · since FY2017: -3230.0% → -975.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -975.9% | -217.7 pp |
| FY2024 | -758.2% | -446.6 pp |
| FY2023 | -311.6% | -9.5 pp |
| FY2022 | -302.0% | +1025.1 pp |
| FY2021 | -1327.1% | -541.6 pp |
| FY2020 | -785.4% | +1841.9 pp |
| FY2019 | -2627.3% | -1249.0 pp |
| FY2018 | -1378.3% | +1851.7 pp |
| FY2017 | -3230.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice